{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T19:07:18Z","timestamp":1793387238049,"version":"4.5.0"},"reference-count":65,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","jacr.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American College of Radiology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.jacr.2024.10.014","type":"journal-article","created":{"date-parts":[[2025,3,3]],"date-time":"2025-03-03T05:17:22Z","timestamp":1740979042000},"page":"260-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2536-0200","authenticated-orcid":false,"given":"Michael","family":"Mohnasky","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Gad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7163-2062","authenticated-orcid":false,"given":"Andrew","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. Sidney","family":"Barritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Resmi A.","family":"Charalel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Eckblad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-0236-7391","authenticated-orcid":false,"given":"Andrew","family":"Caddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minzhi","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nima","family":"Kokabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jacr.2024.10.014_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3322\/caac.21834","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jacr.2024.10.014_bib2","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1053\/j.gastro.2023.01.033","article-title":"Global epidemiology and genetics of hepatocellular carcinoma","volume":"164","author":"Toh","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2024.10.014_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/s41571-023-00825-3","article-title":"Global trends in hepatocellular carcinoma epidemiology: implications for screening, prevention and therapy","volume":"20","author":"Singal","year":"2023","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/j.jacr.2024.10.014_bib4","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1111\/apt.14937","article-title":"Systematic review with meta-analysis: risk of hepatocellular carcinoma in non-alcoholic steatohepatitis without cirrhosis compared to other liver diseases","volume":"48","author":"Stine","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2024.10.014_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.acr.2020.10.001","article-title":"Hepatocellular carcinoma (HCC): epidemiology, etiology and molecular classification","volume":"149","author":"Chidambaranathan-Reghupaty","year":"2021","journal-title":"Adv Cancer Res"},{"key":"10.1016\/j.jacr.2024.10.014_bib6","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1016\/j.cgh.2019.07.060","article-title":"Contemporary epidemiology of chronic liver disease and cirrhosis","volume":"18","author":"Moon","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib7","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1097\/HEP.0000000000000466","article-title":"AASLD practice guidance on prevention, diagnosis, and treatment of hepatocellular carcinoma","volume":"78","author":"Singal","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2024.10.014_bib8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12072-017-9799-9","article-title":"Asia-Pacific clinical practice guidelines on the management of hepatocellular carcinoma: a 2017 update","volume":"11","author":"Omata","year":"2017","journal-title":"Hepatol Int"},{"key":"10.1016\/j.jacr.2024.10.014_bib9","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jhep.2018.03.019","article-title":"EASL clinical practice guidelines: management of hepatocellular carcinoma","volume":"69","year":"2018","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jhep.2021.11.018","article-title":"BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update","volume":"76","author":"Reig","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib11","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/hep.31309","article-title":"Use of hepatocellular carcinoma surveillance in patients with cirrhosis: a systematic review and meta-analysis","volume":"73","author":"Wolf","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2024.10.014_bib12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.cgh.2018.07.029","article-title":"Primary care provider practice patterns and barriers to hepatocellular carcinoma surveillance","volume":"17","author":"Simmons","year":"2019","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib13","doi-asserted-by":"crossref","first-page":"666","DOI":"10.3390\/cancers16030666","article-title":"Management of hepatocellular carcinoma in 2024: the multidisciplinary paradigm in an evolving treatment landscape","volume":"16","author":"Kinsey","year":"2024","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.jacr.2024.10.014_bib14","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1038\/s41575-023-00818-8","article-title":"Hepatocellular carcinoma surveillance\u2014utilization, barriers and the impact of changing aetiology","volume":"20","author":"Huang","year":"2023","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.jhep.2022.01.023","article-title":"HCC surveillance improves early detection, curative treatment receipt, and survival in patients with cirrhosis: a meta-analysis","volume":"77","author":"Singal","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib20","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.3390\/biology11111597","article-title":"Long-term survival and curative-intent treatment in hepatitis B or C virus-associated hepatocellular carcinoma patients diagnosed during screening","volume":"11","author":"Izzo","year":"2022","journal-title":"Biology"},{"key":"10.1016\/j.jacr.2024.10.014_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1258\/096914103771773320","article-title":"Screening for liver cancer: results of a randomised controlled trial in Qidong, China","volume":"10","author":"Chen","year":"2003","journal-title":"J\u00a0Med Screen"},{"key":"10.1016\/j.jacr.2024.10.014_bib22","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s00432-004-0552-0","article-title":"Randomized controlled trial of screening for hepatocellular carcinoma","volume":"130","author":"Zhang","year":"2004","journal-title":"J\u00a0Cancer Res Clin Oncol"},{"key":"10.1016\/j.jacr.2024.10.014_bib23","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.1002\/hep.24581","article-title":"Feasibility of conducting a randomized control trial for liver cancer screening: is a randomized controlled trial for liver cancer screening feasible or still needed?","volume":"54","author":"Poustchi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2024.10.014_bib24","doi-asserted-by":"crossref","first-page":"238","DOI":"10.7326\/L15-5049","article-title":"Screening for hepatocellular carcinoma in chronic liver disease","volume":"162","author":"Chirovsky","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.jacr.2024.10.014_bib25","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.8755","article-title":"Hepatocellular carcinoma screening in a contemporary cohort of at-risk patients","volume":"7","author":"Daher","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacr.2024.10.014_bib26","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1053\/j.gastro.2018.06.079","article-title":"No association between screening for hepatocellular carcinoma and reduced cancer-related mortality in patients with cirrhosis","volume":"155","author":"Moon","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2024.10.014_bib27","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.jhep.2020.11.023","article-title":"Screening is associated with a lower risk of hepatocellular carcinoma-related mortality in patients with chronic hepatitis B","volume":"74","author":"Su","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib28","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1002\/hep.29913","article-title":"Diagnosis, staging, and management of hepatocellular carcinoma: 2018 practice guidance by the American Association for the Study of Liver Diseases","volume":"68","author":"Marrero","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2024.10.014_bib29","first-page":"10","article-title":"Hepatocellular carcinoma surveillance: current practice and future directions","volume":"8","author":"Ahn","year":"2022","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.jacr.2024.10.014_bib30","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.14309\/ajg.0000000000000715","article-title":"Cost-effectiveness of hepatocellular carcinoma surveillance: an assessment of benefits and harms","volume":"115","author":"Parikh","year":"2020","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jacr.2024.10.014_bib31","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.3748\/wjg.v22.i12.3460","article-title":"Cost-effectiveness analysis of population-based screening of hepatocellular carcinoma: comparing ultrasonography with two-stage screening","volume":"22","author":"Kuo","year":"2016","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2024.10.014_bib32","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1111\/j.1365-2036.2004.01963.x","article-title":"Cost-effectiveness of screening for hepatocellular carcinoma in patients with cirrhosis due to chronic hepatitis C","volume":"19","author":"Lin","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2024.10.014_bib33","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.jhep.2021.06.041","article-title":"Risk factors and screening intervals are crucial for evaluating the cost effectiveness of abbreviated MRI in HCC screening","volume":"75","author":"Kutaiba","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2017.26","article-title":"Cost-effectiveness of risk score\u2013stratified hepatocellular carcinoma screening in patients with cirrhosis","volume":"8","author":"Goossens","year":"2017","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.jacr.2024.10.014_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.jhep.2021.01.041","article-title":"Abbreviated MRI for hepatocellular carcinoma screening: a systematic review and meta-analysis","volume":"75","author":"Gupta","year":"2021","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.acra.2024.01.028","article-title":"Abbreviated MRI for hepatocellular carcinoma surveillance\u2014a systematic review and meta-analysis","author":"Maung","year":"2024","journal-title":"Acad Radiol"},{"key":"10.1016\/j.jacr.2024.10.014_bib38","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1111\/apt.15255","article-title":"Clinical course and mortality by etiology of liver cirrhosis in Sweden: a population based, long-term follow-up study of 1317 patients","volume":"49","author":"Nilsson","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2024.10.014_bib39","doi-asserted-by":"crossref","first-page":"9183","DOI":"10.3748\/wjg.v19.i48.9183","article-title":"Transplant benefit for patients with hepatocellular carcinoma","volume":"19","author":"Vitale","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.jacr.2024.10.014_bib40","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1002\/cam4.4551","article-title":"Global burden of primary liver cancer by five etiologies and global prediction by 2035 based on global burden of disease study 2019","volume":"11","author":"Liu","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/j.jacr.2024.10.014_bib41","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.jhep.2021.09.009","article-title":"Comparative performance of risk prediction models for hepatitis B-related hepatocellular carcinoma in the United States","volume":"76","author":"Kim","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jhep.2015.11.035","article-title":"PAGE-B predicts the risk of developing hepatocellular carcinoma in Caucasians with chronic hepatitis B on 5-year antiviral therapy","volume":"64","author":"Papatheodoridis","year":"2016","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib43","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1053\/j.gastro.2018.01.064","article-title":"Surveillance imaging and alpha fetoprotein for early detection of hepatocellular carcinoma in patients with cirrhosis: a meta-analysis","volume":"154","author":"Tzartzeva","year":"2018","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2024.10.014_bib44","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/apt.13841","article-title":"Predictors of adequate ultrasound quality for hepatocellular carcinoma surveillance in patients with cirrhosis","volume":"45","author":"Simmons","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jacr.2024.10.014_bib45","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1148\/radiol.2402051110","article-title":"Effect of obesity on image quality: fifteen-year longitudinal study for evaluation of dictated radiology reports","volume":"240","author":"Uppot","year":"2006","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2024.10.014_bib46","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/j.cgh.2014.02.025","article-title":"Factors that affect efficacy of ultrasound surveillance for early stage hepatocellular carcinoma in patients with cirrhosis","volume":"12","author":"Del Poggio","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib47","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/j.cmet.2022.05.003","article-title":"Changing global epidemiology of liver cancer from 2010 to 2019: NASH is the fastest growing cause of liver cancer","volume":"34","author":"Huang","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/j.jacr.2024.10.014_bib48","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/lt.25398","article-title":"Frequency and outcomes of abnormal imaging in patients with cirrhosis enrolled in a hepatocellular carcinoma surveillance program","volume":"25","author":"Konerman","year":"2019","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jacr.2024.10.014_bib51","article-title":"Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis","volume":"4","author":"Nahon","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jacr.2024.10.014_bib52","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1002\/hep.30330","article-title":"Magnetic resonance imaging is cost-effective for hepatocellular carcinoma surveillance in high-risk patients with cirrhosis","volume":"69","author":"Kim","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jacr.2024.10.014_bib53","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1053\/j.gastro.2017.06.012","article-title":"Risk of hepatocellular cancer in HCV patients treated with direct-acting antiviral agents","volume":"153","author":"Kanwal","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2024.10.014_bib54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.cgh.2021.05.002","article-title":"Incidence of hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: a systematic review, meta-analysis, and meta-regression","volume":"20","author":"Orci","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib55","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib56","doi-asserted-by":"crossref","first-page":"216","DOI":"10.21037\/hbsn-22-469","article-title":"A\u00a0review of 2022 Chinese clinical guidelines on the management of hepatocellular carcinoma: updates and insights","volume":"12","author":"Xie","year":"2023","journal-title":"Hepatobiliary Surg Nutr"},{"key":"10.1016\/j.jacr.2024.10.014_bib57","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1111\/hepr.13814","article-title":"Combined ultrasound and magnetic resonance elastography predict hepatocellular carcinoma after hepatitis C virus eradication","volume":"52","author":"Kumada","year":"2022","journal-title":"Hepatol Res"},{"key":"10.1016\/j.jacr.2024.10.014_bib58","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jhep.2021.11.025","article-title":"HCC risk stratification after cure of hepatitis C in patients with compensated advanced chronic liver disease","volume":"76","author":"Semmler","year":"2022","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/s41575-019-0145-7","article-title":"From NASH to HCC: current concepts and future challenges","volume":"16","author":"Anstee","year":"2019","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib60","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1053\/j.gastro.2019.12.053","article-title":"AGA clinical practice update on screening and surveillance for hepatocellular carcinoma in patients with nonalcoholic fatty liver disease: expert review","volume":"158","author":"Loomba","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jacr.2024.10.014_bib61","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jacr.2024.10.014_bib62","article-title":"Contrast-enhanced ultrasound for the diagnosis of hepatocellular carcinoma in adults with chronic liver disease","volume":"2022","author":"Fraquelli","year":"2022","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jacr.2024.10.014_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.20517\/2394-5079.2022.49","article-title":"Contrast-enhanced ultrasound for hepatocellular carcinoma detection and diagnosis in the context of nonalcoholic fatty liver disease","volume":"9","author":"King","year":"2023","journal-title":"Hepatoma Res"},{"key":"10.1016\/j.jacr.2024.10.014_bib64","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1148\/radiol.2021211244","article-title":"CT\/MRI and CEUS LI-RADS major features association with hepatocellular carcinoma: individual patient data meta-analysis","volume":"302","author":"van der Pol","year":"2022","journal-title":"Radiology"},{"key":"10.1016\/j.jacr.2024.10.014_bib65","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000501082","article-title":"B-mode ultrasonography versus contrast-enhanced ultrasonography for surveillance of hepatocellular carcinoma: a prospective multicenter randomized controlled trial","volume":"8","author":"Kudo","year":"2019","journal-title":"Liver Cancer"},{"key":"10.1016\/j.jacr.2024.10.014_bib66","article-title":"Risk stratification and distribution of hepatocellular carcinomas in CEUS and CT\/MRI LI-RADS: a meta-analysis","volume":"12","author":"Zhou","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.jacr.2024.10.014_bib67","doi-asserted-by":"crossref","first-page":"5743","DOI":"10.3390\/cancers15245743","article-title":"Complementary role of CEUS and CT\/MR LI-RADS for diagnosis of recurrent HCC","volume":"15","author":"Cheng","year":"2023","journal-title":"Cancers"},{"key":"10.1016\/j.jacr.2024.10.014_bib68","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1111\/liv.13429","article-title":"EASL and AASLD recommendations for the diagnosis of HCC to the test of daily practice","volume":"37","author":"Aub\u00e9","year":"2017","journal-title":"Liver Int"},{"issue":"Suppl 6","key":"10.1016\/j.jacr.2024.10.014_bib69","doi-asserted-by":"crossref","first-page":"F99","DOI":"10.1007\/s10406-007-0234-5","article-title":"Economic assessment of contrast-enhanced ultrasonography for evaluation of focal liver lesions: a multicentre Italian experience","volume":"17","author":"Romanini","year":"2007","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2024.10.014_bib70","doi-asserted-by":"crossref","DOI":"10.2214\/AJR.23.30140","article-title":"Abbreviated MRI for hepatocellular carcinoma surveillance: counterpoint\u2014hepatobiliary contrast agents improve detection and characterization","volume":"222","author":"Zhang","year":"2024","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/j.jacr.2024.10.014_bib71","doi-asserted-by":"crossref","first-page":"6929","DOI":"10.1007\/s00330-023-09906-4","article-title":"The combination of non-contrast abbreviated MRI and alpha foetoprotein has high performance for hepatocellular carcinoma screening","volume":"33","author":"Girardet","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jacr.2024.10.014_bib72","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.14309\/ajg.0000000000002636","article-title":"Cost-effectiveness analysis of hepatocellular carcinoma surveillance in nonalcoholic fatty liver disease cirrhosis using US Visualization Score C-triggered abbreviated MRI","volume":"119","author":"Mulgaonkar","year":"2024","journal-title":"Am J Gastroenterol"}],"container-title":["Journal of the American College of Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144024008949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1546144024008949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,10]],"date-time":"2025-03-10T12:24:06Z","timestamp":1741609446000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1546144024008949"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":65,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S1546144024008949"],"URL":"https:\/\/doi.org\/10.1016\/j.jacr.2024.10.014","relation":{},"ISSN":["1546-1440"],"issn-type":[{"value":"1546-1440","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatocellular Carcinoma Screening: From Current Standard of Care to Future Directions","name":"articletitle","label":"Article Title"},{"value":"Journal of the American College of Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacr.2024.10.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American College of Radiology","name":"copyright","label":"Copyright"}]}}